Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Elucidating oncogenic mechanisms of JPO2/CDCA7L - a MYC transforming partner
FY 2016-17
Summary
Medulloblastoma (MB) is the most common type of malignant brain cancer in children. MB can be further divided into four sub-groups with different survival rates. My project will focus on Group 3 MB which is the most aggressive and has the worst prognosis. In this group, the MYC protein is present in very high levels which lead to invasive and metastatic tumours. Metastasis is a major cause of treatment failure and fatality in MB, yet mechanisms that drive MB metastases remains poorly understood. Previously in the Huang lab, we identified JPO2, a novel partner of MYC, which acts as a more powerful oncogene. A combination of JPO2 and MYC was found to increase metastasis in MB tumours. My project is focused on comprehending how JPO2 increases the oncogenic effects of MYC. By understanding the mechanism behind it, we can disrupt the processes involved in order to target the tumour. Recent studies in the Huang lab have found that specific types of mutations in JPO2 aids in the death of MYC expressing cells, suggesting JPO2 might have an important role in cell survival. I will study the structure of the JPO2 protein and examine the different mutants in order to narrow down the specific region essential in killing MYC expressing cells. In the future, we could potentially create a drug that would target that critical region responsible for inducing death in high MYC expressing cells.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367346
Name
Suwal Tannu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating oncogenic mechanisms of JPO2/CDCA7L - a MYC transforming partner
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain; Brain Tumour; Childhood Cancer; Medulloblastoma; Metastasis; Myc; Oncogene; Signalling
Abstract
Medulloblastoma (MB) is the most common type of malignant brain cancer in children. MB can be further divided into four sub-groups with different survival rates. My project will focus on Group 3 MB which is the most aggressive and has the worst prognosis. In this group, the MYC protein is present in very high levels which lead to invasive and metastatic tumours. Metastasis is a major cause of treatment failure and fatality in MB, yet mechanisms that drive MB metastases remains poorly understood. Previously in the Huang lab, we identified JPO2, a novel partner of MYC, which acts as a more powerful oncogene. A combination of JPO2 and MYC was found to increase metastasis in MB tumours. My project is focused on comprehending how JPO2 increases the oncogenic effects of MYC. By understanding the mechanism behind it, we can disrupt the processes involved in order to target the tumour. Recent studies in the Huang lab have found that specific types of mutations in JPO2 aids in the death of MYC expressing cells, suggesting JPO2 might have an important role in cell survival. I will study the structure of the JPO2 protein and examine the different mutants in order to narrow down the specific region essential in killing MYC expressing cells. In the future, we could potentially create a drug that would target that critical region responsible for inducing death in high MYC expressing cells.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Suwal, Tannu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~